CNR Institutional Research Information System

FUSARO, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.099
NA - Nord America 1.375
EU - Europa 654
SA - Sud America 386
Continente sconosciuto - Info sul continente non disponibili 198
AF - Africa 28
OC - Oceania 2
Totale 4.742
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.284
SG - Singapore 882
CN - Cina 430
BR - Brasile 284
IT - Italia 231
VN - Vietnam 224
HK - Hong Kong 197
NL - Olanda 117
FR - Francia 114
BD - Bangladesh 80
JP - Giappone 78
KR - Corea 69
FI - Finlandia 58
CA - Canada 39
IN - India 33
DE - Germania 31
GB - Regno Unito 31
EC - Ecuador 28
AR - Argentina 25
MX - Messico 18
CO - Colombia 16
ID - Indonesia 16
VE - Venezuela 14
IL - Israele 10
TR - Turchia 10
PL - Polonia 9
UA - Ucraina 9
UY - Uruguay 9
JM - Giamaica 8
DZ - Algeria 7
CR - Costa Rica 6
IQ - Iraq 6
SA - Arabia Saudita 6
CL - Cile 5
HN - Honduras 5
UZ - Uzbekistan 5
AM - Armenia 4
CH - Svizzera 4
ES - Italia 4
GR - Grecia 4
KE - Kenya 4
MY - Malesia 4
PH - Filippine 4
RU - Federazione Russa 4
TH - Thailandia 4
ZA - Sudafrica 4
BE - Belgio 3
BH - Bahrain 3
BO - Bolivia 3
BS - Bahamas 3
BY - Bielorussia 3
CZ - Repubblica Ceca 3
EG - Egitto 3
GE - Georgia 3
HU - Ungheria 3
JO - Giordania 3
LK - Sri Lanka 3
LV - Lettonia 3
NP - Nepal 3
PK - Pakistan 3
SE - Svezia 3
TT - Trinidad e Tobago 3
AL - Albania 2
AT - Austria 2
AU - Australia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
EE - Estonia 2
GT - Guatemala 2
IE - Irlanda 2
KW - Kuwait 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MA - Marocco 2
OM - Oman 2
PT - Portogallo 2
PY - Paraguay 2
SV - El Salvador 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BW - Botswana 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GD - Grenada 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MM - Myanmar 1
MN - Mongolia 1
MT - Malta 1
MU - Mauritius 1
MV - Maldive 1
MZ - Mozambico 1
Totale 4.536
Salva come PNG Salva come JPEG
Città #
Singapore 533
Santa Clara 279
Hong Kong 193
Hefei 168
San Jose 155
Ashburn 114
Beijing 103
Lauterbourg 98
Ho Chi Minh City 75
Seoul 67
Tokyo 67
Hanoi 60
Los Angeles 45
Council Bluffs 38
Dallas 36
Lappeenranta 30
New York 28
Helsinki 26
Rome 23
São Paulo 22
Milan 19
Buffalo 18
Haiphong 14
Chicago 13
Orem 13
Guayaquil 12
Atlanta 11
Toronto 11
Belo Horizonte 10
Brasília 10
Minamishinagawa 9
Montevideo 9
Phoenix 9
Warsaw 9
Chennai 8
Florence 8
Munich 8
Quito 8
Rio de Janeiro 8
Amsterdam 7
Bengaluru 7
Can Tho 7
Miami 7
Nuremberg 7
Philadelphia 7
Naples 6
Thái Bình 6
Bari 5
Brooklyn 5
Fortaleza 5
Frankfurt am Main 5
Kingston 5
London 5
Montreal 5
San José 5
Tashkent 5
Athens 4
Bogotá 4
Bắc Giang 4
Caracas 4
Cascina 4
Charlotte 4
Da Nang 4
Detroit 4
Elk Grove Village 4
Nairobi 4
Newark 4
Palermo 4
Santiago 4
The Bronx 4
Volta Redonda 4
Amman 3
Anaheim 3
Baghdad 3
Brescia 3
Bắc Ninh 3
Cagliari 3
Campinas 3
Campo Grande 3
Carapicuíba 3
Catania 3
Colombo 3
Columbia 3
Contagem 3
Denpasar 3
Falkenstein 3
Figino 3
Georgetown 3
Gustavo Adolfo Madero 3
Hangzhou 3
Hyderabad 3
Lubbock 3
Madrid 3
Manama 3
Manaus 3
Maracaibo 3
Mesa 3
Mexico City 3
Nassau 3
New Delhi 3
Totale 2.613
Salva come PNG Salva come JPEG
Nome #
Bone Mineral Density Predicts Fractures in Chronic Kidney Disease 103
Distance from the outbreak of infection, ozone pollution and public health consequences of SARS-CoV-2 epidemic: the HOPE method 99
Bone Biopsy for Histomorphometry in Chronic Kidney Disease (CKD): State-of-the-Art and New Perspectives 92
[Biomarkers and Bone Turnover Markers in Chronic Kidney Disease - Mineral and Bone Disorders (CKD-MBD): Recent Advances] 84
Methods to Analyze Time-to-Event Data: The Cox Regression Analysis 78
Vitamin K2 is a key regulator of clinically relevant molecular processes 73
Overweight-obesity is associated with decreased vitamin K2 levels in hemodialysis patients 73
Fundamentals and Applications of the Receiver Operating Characteristic Curve Analysis in the Research of Endothelial Dysfunction in Chronic Kidney Disease 72
Calcimimetic and vitamin D analog use in hemodialyzed patients is associated with increased levels of vitamin K dependent proteins 69
The Role of Vitamin K in CKD-MBD 67
Vitamin K in CKD Bone Disorders 66
Vitamin D and Chronic Kidney Disease Association with Mineral and Bone Disorder: An Appraisal of Tangled Guidelines 61
SEVELAMER USE IS ASSOCIATED WITH DECREASED VITAMIN K LEVELS IN HEMODIALYSIS PATIENTS: RESULTS FROM VITAMIN K ITALIAN (VIKI) STUDY. 61
A Novel Quantitative Computer-Assisted Score Can Improve Repeatability in the Estimate of Vascular Calcifications at the Abdominal Aorta 58
Sevelamer Use, Vitamin K Levels, Vascular Calcifications, and Vertebral Fractures in Hemodialysis Patients: Results from the VIKI Study 58
Chronic Hyperkalemia in Cardiorenal Patients: Risk Factors, Diagnosis, and New Treatment Options 57
Time for Revival of Bone Biopsy with Histomorphometric Analysis in Chronic Kidney Disease (CKD): Moving from Skepticism to Pragmatism 57
Alkaline Phosphatase: An Old Friend as Treatment Target for Cardiovascular and Mineral Bone Disorders in Chronic Kidney Disease 57
Methods to Analyse Time-to-Event Data: The Kaplan-Meier Survival Curve 54
Romosozumab Use and Cardiovascular Events 54
Non-Traditional Aspects of Renal Diets: Focus on Fiber, Alkali and Vitamin K1 Intake 54
Simple Statistical Measures for Assessing the Accuracy of a Diagnostic Test in Clinical Medicine 54
Haemorragic and thromboembolic risk in CKD patients with non valvular atrial fibrillation: Do we need a novel risk score calculator? 53
Real-World Analysis of Outcomes and Economic Burden in Patients with Chronic Kidney Disease with and without Secondary Hyperparathyroidism among a Sample of the Italian Population 53
Rationale and Protocol of the ETERNITY-ITA Study: Use of Etelcalcetide for Preserving Vitamin K-Dependent Protein Activity-An Italian Study 53
The Vessels-Bone Axis: Iliac Artery Calcifications, Vertebral Fractures and Vitamin K from VIKI Study 52
Sex-related differences in vitamin D testing in the Veneto Region, Italy: a retrospective analysis from 2005 to 2016 51
Vitamin D assay and supplementation: still debatable issues 49
Ten tips on how to assess bone health in patients with chronic kidney disease 48
New Insight into the Role of Vitamin D in the Stroke Risk: A Meta-Analysis of Stratified Data by 25(OH)D Levels 47
Evaluating Osteoporosis in Chronic Kidney Disease: Both Bone Quantity and Quality Matter 46
Real-world usage of Chronic Kidney Disease – Mineral Bone Disorder (CKD–MBD) biomarkers in nephrology practices 46
Vertebral fractures in patients with CKD and the general population: a call for diagnosis and action 46
Oral Calcitriol Use, Vertebral Fractures, and Vitamin K in Hemodialysis Patients: A Cross-Sectional Study 45
Vitamin K and kidney transplantation 45
Effect of Antidiabetic Drugs on Bone Health in Patients with Normal Renal Function and in Chronic Kidney Disease (CKD): Insight into Clinical Challenges in the Treatment of Type 2 Diabetes 45
Changes in Bone Quality after Treatment with Etelcalcetide 45
Tubular phosphate transport: a comparison between different methods of urine sample collection in FGF23-dependent hypophosphatemic syndromes 45
Vitamin K and cardiovascular calcification in CKD: is patient supplementation on the horizon? 44
Osteocalcin (bone GLA protein) levels, vascular calcifications, vertebral fractures and mortality in hemodialysis patients with diabetes mellitus 44
Native vitamin D in CKD and renal transplantation: meaning and rationale for its supplementation 44
Vitamin K plasma levels determination in human health 43
Comprehensive Associations between Acidosis and the Skeleton in Patients with Kidney Disease 43
Phosphate and bone fracture risk in chronic kidney disease patients 43
Management of secondary hyperparathyroidism in uremic patients: the role of the new vitamin D analogs 42
Vitamin K and osteoporosis 41
Vitamin K and bone 40
Clinical relevance and future perspective of fractures in patients with chronic kidney disease 40
Efficacy of vitamin K on bone fragility: puzzling findings from which we should learn how to design a rigorous study 39
Thromboembolic and Bleeding Risk in Atrial Fibrillation Patients with Chronic Kidney Disease: Role of Anticoagulation Therapy 39
A diagnostic-therapeutic pathway for patients with kidney stone disease: 2020 update 39
Treatment of Vitamin K Deficiency in Hemodialysis Patients - A Pilot Study Comparing Menaquinone-7 Tablets and a Vitamin K Rich Diet 38
Evaluating benefit from vitamin D supplementation: defining the area for treatment 38
High-resolution peripheral quantitative computed tomography: research or clinical practice? 37
Predictive Value of Measures of Vascular Calcification Burden and Progression for Risk of Death in Incident to Dialysis Patients 37
The relationship between the Spine Deformity Index, biochemical parameters of bone metabolism and vascular calcifications: results from the Epidemiological VERtebral FRACtures iTalian Study (EVERFRACT) in dialysis patients 37
Cardiac valve calcification and use of anticoagulants: Preliminary observation of a potentially modifiable risk factor 36
Low vitamin K1 intake in haemodialysis patients 36
Fragility fracture in the Chronic Kidney Disease (CKD) 36
CHRONIC PROTON PUMP INHIBITOR TREATMENT IS ASSOCIATED WITH AN INCREASED RISK OF VASCULAR CALCIFICATIONS IN CHRONIC KIDNEY DISEASE 36
Efficacy of weekly administration of cholecalciferol on parathyroid hormone in stable kidney-transplanted patients with CKD stage 1–3 36
Percorso diagnostico-terapeutico per il paziente con calcolosi renale: update 2020 35
HO-1 Attenuates Hypertension-Induced Inflammation/Oxidative Stress: Support From Bartter's/Gitelman's Patients 35
A new CHA2DS2VASC score integrated with eGFR, left ventricular hypertrophy, and pulse pressure is highly effective in predicting adverse cardiovascular outcome in chronic kidney disease. 35
Current and Emerging Markers and Tools Used in the Diagnosis and Management of Chronic Kidney Disease–Mineral and Bone Disorder in Non-Dialysis Adult Patients 35
Cardiovascular Safety and Effectiveness of Bisphosphonates: From Intervention Trials to Real-Life Data 34
Vitamin K effects in human health: new insights beyond bone and cardiovascular health (vol 33, pg 239, 2020) 34
Increased Risk of Bone Fractures in Hemodialysis Patients Treated with Proton Pump Inhibitors in Real World: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS) 34
Safety and effectiveness of rivaroxaban and warfarin in moderate-to-advanced CKD: real world data 33
Vitamin K, bone fractures, and vascular calcifications in chronic kidney disease: An important but poorly studied relationship 33
Systematic DOACs oral anticoagulation in patients with atrial fibrillation and chronic kidney disease: the nephrologist's perspective 32
Effectiveness of in-hospital cholecalciferol use on clinical outcomes in comorbid covid-19 patients: A hypothesis-generating study 32
Adverse effects of proton pump inhibitors in chronic kidney disease 32
Reduction of Hyperphosphatemia is Related with the Reduction of C-Reactive Protein in Dialysis Patients. Study in Sevelamer-Resistant Dialysis Patients Treated with Chitosan Chewing Gum as Salivary Phosphate Binder 32
Vitamin K effects in human health: new insights beyond bone and cardiovascular health 32
High Prevalence of Vertebral Fractures Assessed by Quantitative Morphometry in Hemodialysis Patients, Strongly Associated with Vascular Calcifications 31
Fractures in chronic kidney disease: neglected, common, and associated with sickness and death 31
Vitamin K antagonists and osteoporotic fractures: insights from comparisons with the NOACs 31
Adverse Effects of Proton Pump Inhibitors in Chronic Kidney Disease 31
Efficacy of weekly administration of cholecalciferol on parathyroid hormone in stable kidney-transplanted patients with CKD stage 1-3 30
WARFARIN USE IS ASSOCIATED WITH HIGHER PREVALENCE VERTEBRAL FRACTURES, VASCULAR CALCIFICATIONS AND INCREASED MORTALITY IN CHRONIC KIDNEY DISEASE 30
SIRT1, heme oxygenase-1 and NO-mediated vasodilation in a human model of endogenous angiotensin II type 1 receptor antagonism: Implications for hypertension 30
Vertebral fractures in patients on dialysis: a clinically relevant problem with insufficient investigation 30
Utility of Cardiac Biomarkers in the Setting of Kidney Disease 30
Effect of olmesartan on oxidative stress in hypertensive patients. Mechanistic support to clinical trials derived evidence 29
CIGARETTE SMOKING IS ASSOCIATED WITH DECREASED BGP LEVELS IN HEMODIALYSIS PATIENTS 29
Atrial fibrillation and low vitamin D levels are associated with severe vascular calcifications in hemodialysis patients 29
Treatment with Calcimimetic (Cinacalcet) Alters Epoetin Dosage Requirements in Dialysis Patients: Preliminary Report 28
DECREASED OSTEOCALCIN LEVELS AND INCREASED MORTALITY IN HEMODIALYSIS PATIENTS WITH DIABETES MELLITUS 28
The Role of Vitamin K in Vascular Calcification 28
Effect of neridronate in osteopenic patients after heart, liver or lung transplant: a multicenter, randomized, double-blind, placebo-controlled study 27
VITAMIN K DEPENDENT PROTEINS AFTER KIDNEY TRANSPLANTATION: RESULTS FROM PROSPECTIVE STUDY. 27
EVALUATION OF VITAMIN D STATUS DURING KIDNEY TRANSPLANTATION: FACTORS RELATED AND EFFECT OF THE TREATMENT 27
Vitamin K and bone metabolism in the elderly with normal and reduced kidney function 26
HIGHER BMI IS ASSOCIATED WITH DECREASED VITAMIN K2 LEVELS IN HEMODIALYSIS PATIENTS 26
Vertebral fractures in dialysis: Endocrinological disruption of the bone-kidney axis 26
The treatment of the patient presenting with chronic kidney disease (CKD) and fragility fractures 26
THE RELATIONSHIP BETWEEN THE SPINE DEFORMITY INDEX BIOCHEMICAL PARAMETERS OF BONE METABOLISM AND VASCULAR CALCIFICATIONS: RESULTS FROM THE EPIDEMIOLOGICAL VERTEBRAL FRACTURES ITALIAN STUDY IN DIALYSIS PATIENTS (EVERFRACT STUDY) 25
BONE DISEASE THERAPY IN CKD CAN INFLUENCE LEVELS VITAMIN K DEPENDENT PROTEINS (VIKI STUDY) 25
Vitamin K, bone fractures, and vascular calcifications in chronic kidney disease: An important but poorly studied relationship 25
Totale 4.351
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.442
article - articoli 16.472
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 237
Totale 35.151
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20249 0 0 0 0 0 0 0 0 0 3 5 1
2024/20251.671 2 6 98 85 443 45 76 74 47 132 376 287
2025/20262.478 123 215 248 347 402 52 347 138 174 174 112 146
2026/2027584 153 121 310 0 0 0 0 0 0 0 0 0
Totale 4.742